Without even solving the puzzle, but reasoning purely on circumstantial evidence, the answer has to be Mike Hunkapillar's stealth startup Pacific Biosystems. The reasons are simple ... (1) PB's genomic technology is producing a flood of raw data, (2) PB therefore needs programmers to convert that stream into IPO-salable value, and (3) PB is the only one hiring right now!